Mozaffar, T., Bratkovic, D., Byrne, B. J., Clemens, P., Geberhiwot, T., Goker-Alpan, O., … Schoser, B. (2018). FIRST-IN-HUMAN STUDY OF AT-GAA (ATB200/AT2221) IN PATIENTS WITH POMPE DISEASE: PRELIMINARY RESULTS FROM THE ATB200-02 TRIAL. In MUSCLE & NERVE (Vol. 58, pp. S1–S1). Oxford, ENGLAND: WILEY.

Mozaffar, T., D. Bratkovic, B. J. Byrne, P. Clemens, T. Geberhiwot, O. Goker-Alpan, P. Kishnani, et al. “FIRST-IN-HUMAN STUDY OF AT-GAA (ATB200/AT2221) IN PATIENTS WITH POMPE DISEASE: PRELIMINARY RESULTS FROM THE ATB200-02 TRIAL.” In MUSCLE & NERVE, 58:S1–S1. WILEY, 2018.

Mozaffar T, Bratkovic D, Byrne BJ, Clemens P, Geberhiwot T, Goker-Alpan O, et al. FIRST-IN-HUMAN STUDY OF AT-GAA (ATB200/AT2221) IN PATIENTS WITH POMPE DISEASE: PRELIMINARY RESULTS FROM THE ATB200-02 TRIAL. In: MUSCLE & NERVE. WILEY; 2018. p. S1–S1.

Mozaffar, T., et al. “FIRST-IN-HUMAN STUDY OF AT-GAA (ATB200/AT2221) IN PATIENTS WITH POMPE DISEASE: PRELIMINARY RESULTS FROM THE ATB200-02 TRIAL.” MUSCLE & NERVE, vol. 58, WILEY, 2018, pp. S1–S1.

Mozaffar T, Bratkovic D, Byrne BJ, Clemens P, Geberhiwot T, Goker-Alpan O, Kishnani P, Ming X, Roberts M, Schwenkreis P, Sivakumar K, van der Ploeg AT, Wright J, Johnson FK, Sitaraman S, Barth JA, Sathe S, Schoser B. FIRST-IN-HUMAN STUDY OF AT-GAA (ATB200/AT2221) IN PATIENTS WITH POMPE DISEASE: PRELIMINARY RESULTS FROM THE ATB200-02 TRIAL. MUSCLE & NERVE. WILEY; 2018. p. S1–S1.